阿片类药物管理:成功、可扩展且可适配的科室级阿片减量项目
该研究在短期护理、结直肠、胸科、移植和外科肿瘤等15种择期手术中实施包含多媒体教育、处方徽章、4项电子病历修改和处方监测面板的综合阿片管理项目。6,619例阿片初治成人(实施前2,334例、实施后4,285例)分析显示,出院处方量中位数从5片降至0片,平均处方量下降67.1%,14/15种手术处方量显著减少。
要点
- 综合多阶段阿片管理项目可显著降低术后出院阿片处方量
- 实施后患者出院带阿片处方减少8片(按羟考酮5mg片计)
- 出院带阿片处方者后续再获处方的比值比为3.90
核心结论
- 低成本、自我维持的科室级阿片管理项目能显著减少常见手术后出院时的阿片过度处方。
研究设计与样本
- 回顾性分析2019年基线出院处方习惯,并与2021至2022年前瞻性实施后数据比较。
- 纳入本机构短期护理、结直肠、胸科、移植和外科肿瘤部门15种择期手术的阿片初治成人,共6,619例(实施前2,334例,实施后4,285例)。
- 项目包括多媒体患者与员工教育材料、处方徽章、4项电子病历修改及追踪分析阿片处方的监测面板。
主要发现
- 出院处方量中位数(四分位距)从5(0至15)片降至0(0至5)片(p<0.0001)。
- 平均(标准差)处方量从8.7±12.9片降至2.9±7.1片,减少67.1%,节省24,212片。
- 15种手术中14种出院阿片处方中位数减少(均p<0.05,范围37.1%至89.6%),10种手术实施后处方量中位数为0。
- 风险调整后,实施后出院带阿片处方的患者少接受8片羟考酮5mg片(p<0.0001)。
- 实施后时期与出院处方达标比值比8.9(7.74至10.18)、无阿片出院比值比3.4(3.06至3.87)增加相关,与获得处方续配比值比0.72(0.59至0.88)降低相关。
关键数值与推荐
- 主要结局包括出院处方量(归一化为羟考酮5mg片)、阿片减少百分比及出院后需要阿片处方的患者百分比。
- 与无阿片出院患者相比,出院带阿片处方者获得另一次出院后处方的比值比为3.90(3.12至4.86)。
临床怎么用
- 可将多媒体教育、处方徽章、电子病历修改和监测面板组合为科室级阿片管理项目,以降低术后出院阿片处方量。
- 关注出院带阿片处方患者,因其后续再获阿片处方的风险更高。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-phase efforts to reduce opioid prescriptions after surgery have been somewhat effective. This is the first report of a low-cost, scalable, and self-sustaining opioid stewardship program spanning all perioperative phases. STUDY DESIGN: We implemented a comprehensive opioid stewardship program comprised of multimedia patient- and staff-directed educational materials, prescribing badges, 4 electronic medical record modifications, and a dashboard that tracked and analyzed opioid prescribing. A retrospective analysis of baseline discharge prescribing habits (2019) was compared with prospective postimplementation data (2021 to 2022). Opioid naive adults undergoing 1 of 15 elective procedures in the short-term care, colorectal, thoracic, transplant, and surgical oncology divisions at our institution were included. Primary outcomes included discharge prescription size (normalized to oxycodone 5 mg pills), percent reduction of opioids, and percentage of patients requiring postdischarge opioid prescription. RESULTS: A total of 6,619 adults (median age 59 years [interquartile range 36 to 82 years]; 69.7% woman) were enrolled, 2,334 before and 4,285 after implementation. Overall, median (interquartile range) prescription size decreased (5 [0 to 15] to 0 [0 to 5; p < 0.0001]) and average (SD) decreased from 8.7 ± 12.9 to 2.9 ± 7.1 for a 67.1% reduction and a savings of 24,212 pills. A reduction in median discharge opioid prescription was achieved in 14 of 15 procedures (all p < 0.05, range 37.1% to 89.6%), and the median postintervention prescription quantity was 0 for 10 of 15 procedures. After risk adjustment, postintervention patients discharged with opioid prescriptions received 8 fewer oxycodone 5 mg pills (p < 0.0001). The postintervention period was associated with increased odds of discharge on-target (odds ratio [OR] 8.9 [7.74 to 10.18] and opioid-free discharge (OR 3.4 [3.06 to 3.87]) and reduced odds of receiving a prescription refill (OR 0.72 [0.59 to 0.88]). Compared with patients who were discharged without opioids, those who were discharged with an opioid prescription had increased odds of receiving another postdischarge prescription (OR 3.90 [3.12 to 4.86]). CONCLUSIONS: This low-cost, self-sustaining departmental opioid stewardship program was remarkably effective at reducing opioid overprescription at discharge after common operations.
引用
- Melucci AD, Lynch O, Lawrence M, et al. Opioid Stewardship: Successful, Scalable, and Adaptable Departmental Opioid Reduction Program. J Am Coll Surg. 2025. PMID: 41051106. doi:10.1097/XCS.0000000000001482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。